pentadecapeptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.
BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.
The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.
| Property | Value | Notes |
|---|---|---|
| Main study model | Rodents, rats and mice | Underpins most of the published data |
| Common routes in studies | Subcutaneous, intraperitoneal, oral | Varies with the experimental design |
| Common analytical method | Reversed-phase HPLC, LC-MS | Used for identity and purity checks |
| Human evidence base | Small | Few trials reported, with limited findings |
| Regulatory status | Varies by jurisdiction | Not an approved medicine in most places |
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
=== 1990 === January 19–20: Soviet troops kill at least 131 Azerbaijanis for demonstrating for independence in Baku. January 30: the Polish United Workers' Party is dissolved, allowing democracy to be restored in Poland. January 31: U.S. Operation Just Cause ends, and Operation Promote Liberty begins in Panama. February 12–14: The Dushanbe riots occurred in Tajikistan. March 11: Lithuania declares independence from the Soviet Union. March 21: South Africa give de jure independence to South West Africa (Namibia). April 3: The Bulgarian Communist Party, the ruling party of Bulgaria, is dissolved. May 22: Both North Yemen and South Yemen unified. May 29: Boris Yeltsin is elected as the president of Russia. Yeltsin would serve as Russia's president until resigning on December 31, 1999, with Vladimir Putin taking over. May 30: The Washington Summit begins. June 12: Russia issues the Declaration of Sovereignty but never officially declares its independence from the Soviet Union. With the declaration, it declares that the laws and constitution of the Russian Soviet Federated Socialist Republic (RSFSR) to be above those of the Soviet Union. The loss of the RSFSR which was the most powerful of all the Soviet republics is a major blow to the Soviet Union. August 2: Ba'athist Iraq invades Kuwait, igniting the Gulf War. August 20: Estonia declares independence from the Soviet Union. August 23: Armenia declares independence from the Soviet Union. September 9: George H. W.
Rotary vane pump, the most common Diaphragm pump, zero oil contamination Liquid ring high resistance to dust Piston pump, fluctuating vacuum Scroll pump, highest speed dry pump Screw pump (10 Pa) Wankel pump External vane pump Roots blower, also called a booster pump, has highest pumping speeds but low compression ratio Multistage Roots pump that combine several stages providing high pumping speed with better compression ratio Toepler pump Lobe pump The base pressure of a rubber- and plastic-sealed piston pump system is typically 1 to 50 kPa, while a scroll pump might reach 10 Pa (when new) and a rotary vane oil pump with a clean and empty metallic chamber can easily achieve 0.1 Pa. A positive displacement vacuum pump moves the same volume of gas with each cycle, so its pumping speed is constant unless it is overcome by backstreaming.
For those with neuroendocrine cancers the number alive after five years is much better at 65%, varying considerably with type. A solid pseudopapillary tumour is a low-grade malignant tumour of the pancreas of papillary architecture that typically afflicts young women.
=== Biosynthesis === Like other steroid hormones, testosterone is derived from cholesterol (Figure 1). The first step in the biosynthesis involves the oxidative cleavage of the side-chain of cholesterol by cholesterol side-chain cleavage enzyme (P450scc, CYP11A1), a mitochondrial cytochrome P450 oxidase with the loss of six carbon atoms to give pregnenolone. In the next step, two additional carbon atoms are removed by the CYP17A1 (17α-hydroxylase/17,20-lyase) enzyme in the endoplasmic reticulum to yield a variety of C19 steroids. In addition, the 3β-hydroxyl group is oxidized by 3β-hydroxysteroid dehydrogenase to produce androstenedione. In the final and rate limiting step, the C17 keto group androstenedione is reduced by 17β-hydroxysteroid dehydrogenase to yield testosterone. The largest amounts of testosterone (>95%) are produced by the testes in men, while the adrenal glands account for most of the remainder. Testosterone is also synthesized in far smaller total quantities in women by the adrenal glands, thecal cells of the ovaries, and, during pregnancy, by the placenta. In the testes, testosterone is produced by the Leydig cells. The male generative glands also contain Sertoli cells, which require testosterone for spermatogenesis. Like most hormones, testosterone is supplied to target tissues in the blood where much of it is transported bound to a specific plasma protein, sex hormone-binding globulin (SHBG).
=== Some roles in development === Since G protein–coupled receptors are known to activate Signal transduction in cells, it should not be surprising to find MC1R involved in development. As one example at the cellular level, preventing signalling by MC1R stopped erythropoiesis from proceeding from the polychromatic cell stage (poly-E in the figure) to the orthochromatic cell stage (ortho-E in the diagram). The same report showed that neutralizing antibodies to MC1R prevented phosphorylation of STAT5 by erythropoietin, and that MC2R and MC5R were also involved, as shown in their model.
Sources: en.wikipedia.org
=== Improving vaccination coverage === Turner has been involved in research into how the structures and organisation of general practice are associated with immunisation coverage in New Zealand. A 2010 paper, co-authored by Turner concluded that while practice immunisation coverage and timeliness did vary widely in New Zealand, "organisational and structural aspects of general practices are key determinants of general practice immunisation delivery". Turner co-authored an Immunisation Advisory Centre (IMAC) study in 2011 that assessed the effectiveness of the cold chain management for delivery of childhood vaccines from national stores to delivery sites in New Zealand. In 2018, IMAC collated a synopsis of strategies used since the 1918 influenza pandemic to deal with unanswered questions about how to manage future pandemics. The data indicated that the burden of the disease in 1918 in New Zealand was inequitably carried by vulnerable populations such as the Maori, Pacific Island and Asian communities. In a related research project, Turner and epidemiologists Nick Wilson and Michael Baker presented data that showed the birth rate for Maori dropped disproportionately after the 2018 pandemic, confirming the importance of pregnant women being vaccinated against seasonal influenza to reduce the rate of stillbirths.
==== Exfoliation with supercritical carbon dioxide ==== Liquid-phase exfoliation can also be done by a less-known process of intercalating supercritical carbon dioxide (scCO2) into the interstitial spaces in the graphite lattice, followed by rapid depressurization. The scCO2 intercalates easily inside the graphite lattice at a pressure of roughly 100 atm. Carbon dioxide turns gaseous as soon as the vessel is depressurized and makes the graphite explode into few-layered graphene. This method may have multiple advantages: being non-toxic, the graphite does not have to be chemically treated in any way before the process, and the whole process can be completed in a single step as opposed to other exfoliation methods.
In the human body, the epithelial cells of the small intestine produce citrulline, primarily from glutamine and glutamate, which is secreted into the bloodstream which carries it to the proximal tubule cells of the kidney, which extract the citrulline and convert it to arginine, which is returned to the blood. This means that impaired small bowel or renal function can reduce arginine synthesis and thus create a dietary requirement for arginine. For such a person, arginine would become "essential". Synthesis of arginine from citrulline also occurs at a low level in many other cells, and cellular capacity for arginine synthesis can be markedly increased under circumstances that increase the production of inducible nitric oxide synthase (NOS). This allows citrulline, a byproduct of the NOS-catalyzed production of nitric oxide, to be recycled to arginine in a pathway known as the citrulline to nitric oxide (citrulline-NO) or arginine-citrulline pathway. This is demonstrated by the fact that, in many cell types, nitric oxide synthesis can be supported to some extent by citrulline, and not just by arginine. This recycling is not quantitative, however, because citrulline accumulates in nitric oxide producing cells along with nitrate and nitrite, the stable end-products of nitric oxide breakdown. In bacteria, biosynthesis proceeds via acetylation intermediates. Glutamate is acetylated to N-acetylglutamate and subsequently converted to N-acetylornithine via N-acetylglutamylphosphate and N-acetylglutamate semialdehyde.
=== Acid-base reactions === Fatty acids do not show a great variation in their acidities, as indicated by their respective pKa. Nonanoic acid, for example, has a pKa of 4.96, being only slightly weaker than acetic acid (4.76). As the chain length increases, the solubility of the fatty acids in water decreases, so that the longer-chain fatty acids have minimal effect on the pH of an aqueous solution. Near neutral pH, fatty acids exist at their conjugate bases, i.e. oleate, etc. Solutions of fatty acids in ethanol can be titrated with sodium hydroxide solution using phenolphthalein as an indicator. This analysis is used to determine the free fatty acid content of fats; i.e., the proportion of the triglycerides that have been hydrolyzed. Neutralization of fatty acids, like saponification, is a widely practiced route to metallic soaps.
== Limitations of mechanical micronization == Although mechanical micronization is the most widely used industrial technique, the high specific energy delivered by milling can alter the solid-state properties of the active beyond simple size reduction. The most extensively documented consequence is partial conversion of crystalline material to the amorphous state at the newly created particle surfaces. Because the amorphous state has higher free energy, greater hygroscopicity, and faster dissolution than the parent crystal, surface amorphization can shift dissolution behaviour, accelerate moisture uptake, and recrystallize uncontrollably during storage — altering the very properties micronization was performed to achieve. Mechanical stress can also drive polymorphic conversion between crystalline forms or induce conversion from anhydrous to hydrated phases (and vice versa). The thermodynamic driving force is provided by the cumulative mechanical energy absorbed by the lattice; in some cases the milled product passes through an amorphous intermediate before recrystallizing into a different polymorph than the starting material. Because different polymorphs and hydrates have different solubility, dissolution rate, and bioavailability, mill-induced polymorphic conversion is a critical quality attribute that must be monitored by techniques such as X-ray powder diffraction, differential scanning calorimetry, and Raman spectroscopy.
Sources: en.wikipedia.org
==== 2021 ==== Researchers report that myeloid cells are drivers of a maladaptive inflammation element of brain-ageing in mice and that this can be reversed or prevented via inhibition of their EP2 signalling. A randomized clinical trial demonstrates that a combination therapy of a short (two months) intervention of diet, phytonutrient and probiotics supplementation, exercise, relaxation and further lifestyle changes can lead to substantial decrease of the Horvath DNAmAge Epigenetic clock epigenetic aging biomarker in healthy adults and that such may therefore be, measurable, DNA methylome rejuvenation guidance. Scientists report alternative approach to senolytics for removing senescent cells: invariant NKT (iNKT) cells. Scientists demonstrate a tool to calculate a person's inflammatory age (iAge) based on patterns of systemic age-related inflammation and identify cytokine CXCL9 as a key suppression target. A study indicates gut microbiomes with large amounts of microbes capable of generating unique secondary bile acids are a key element of centenarians' longevity. Scientists identify genetic determinants of ovarian ageing and possible effects of extending fertility in women. Scientists show that transplantation of fecal microbiota from young donor mice into aged recipient mice substantially rejuvenates the brains of the latter, complementing similar results of a 2020 study.
Although telomerase has telomerase reverse transcriptase as a catalytic subunit, regulation is accomplished by factors outside the protein. An enzyme composed of both regulatory and catalytic subunits when assembled is often referred to as a holoenzyme. For example, class I phosphoinositide 3-kinase is composed of a p110 catalytic subunit and a p85 regulatory subunit. One subunit is made of one polypeptide chain. A polypeptide chain has one gene coding for it – meaning that a protein must have one gene for each unique subunit.
The light from LEDs can be modulated very quickly so they are used extensively in optical fiber and free-space optics communications. This includes remote controls, such as for television sets, where infrared LEDs are often used. Opto-isolators use an LED combined with a photodiode or phototransistor to provide a signal path with electrical isolation between two circuits. This is especially useful in medical equipment where the signals from a low-voltage sensor circuit (usually battery-powered) in contact with a living organism must be electrically isolated from any possible electrical failure in a recording or monitoring device operating at potentially dangerous voltages. An opto-isolator also lets information be transferred between circuits that do not share a common ground potential. Many sensor systems rely on light as the signal source. LEDs are often ideal as a light source due to the requirements of the sensors. The Nintendo Wii's sensor bar uses infrared LEDs. Pulse oximeters use them for measuring oxygen saturation. Some flatbed scanners use arrays of RGB LEDs rather than the typical cold-cathode fluorescent lamp as the light source. Having independent control of three illuminated colors allows the scanner to calibrate itself for more accurate color balance, and there is no need for warm-up. Further, its sensors only need be monochromatic, since at any one time the page being scanned is only lit by one color of light. Since LEDs can also be used as photodiodes, they can be used for both photo emission and detection.
For services to the Arts and to the community in Southend-on-Sea, Essex. Dr. Alasdair Cunningham Bruce. Boston Spa Renewed Programme Manager. For services to Libraries. Christopher John Paul Bryant. Director of Tournaments and Events, Football Association. For services to Sport. Jennifer Sheridan Bryer. Teacher, Pony Club. For services to Horse Riding. Peter George Buchan. Managing Director, Shipping, Nuclear Transport Solutions. For services to the Nuclear Industry and to Young People. Khumi Tonsing Burton, JP, DL. For services to the community in Manchester and Cheshire. Ronald Butler. Policy Adviser, Department for Work and Pensions. For services to Disadvantaged People. Carrie Byrom. Director, Stable Lives. For services to Mental Health and the community in North West England. David Corrie Calvert. President, Langholm Town Band. For services to the community in Langholm, Dumfries. Carl Campbell. Founder and Artistic Director, CCDC7. For services to African Caribbean Dance Education and Culture. Catriona Yvonne Fiona Campbell. UK&I Chief Technology and Innovation Officer, EY. For services to Technology and Innovation. George Alan Carney. Executive Officer, Department for Education. For Public Service. Professor Kathryn Janice Carruthers. Professor of French Linguistics, Queen's University Belfast. For services to Modern Languages. Kathryn Melanie Keele Caton. Founder and Managing Director, Brighton Gin. For services to Trade and to the community in Brighton. Amanda Chadwick. Founder and Trustee, Pyjama Fairies. For services to Children in Hospital. Edward Kay Kiu Chan.
Sources: en.wikipedia.org
Animal experiments form the bulk of the published record. Rodent models of tendon, ligament, bone, and gut injury are the most common designs. Controlled human trials are rare, which limits confidence in any clinical claim.
They are best described as working hypotheses. Supporting data come mainly from cell cultures and animal tissue, using markers such as growth factors and inflammatory signals. Confirmatory human studies have not been reported.
Status depends on the country. In some places it is treated as a research chemical available without a prescription, while elsewhere it falls under prescription or controlled rules. It holds no general marketing approval as a therapeutic product.
The peptide is synthetic, but its sequence matches a segment of a protein present in human gastric juice. It does not occur as a free fifteen-residue peptide in the body.